Publications en collaboration avec des chercheurs de Hospital General Universitario Gregorio Marañón (19)

2024

  1. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

  2. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

    Haematologica, Vol. 109, Núm. 2, pp. 543-552

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Chronic Venous Disease during Pregnancy Is Related to Inflammation of the Umbilical Cord: Role of Allograft Inflammatory Factor 1 (AIF-1) and Interleukins 10 (IL-10), IL-12 and IL-18

    Journal of Personalized Medicine, Vol. 13, Núm. 6

  3. Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols

    HemaSphere

2021

  1. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

    Leukemia Research, Vol. 109

  2. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

2019

  1. Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers

    Scientific Reports, Vol. 9, Núm. 1

  2. Clinical and molecular comparative study of colorectal cancer based on age-of-onset and tumor location: Two main criteria for subclassifying colorectal cancer

    International Journal of Molecular Sciences, Vol. 20, Núm. 4

  3. Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer

    PLoS ONE, Vol. 14, Núm. 5

  4. Redefining synchronous colorectal cancers based on tumor clonality

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1596-1608

2018

  1. Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location

    Oncotarget, Vol. 9, Núm. 20, pp. 15302-15311

2017

  1. Toward a Molecular Classification of Synchronous Colorectal Cancer: Clinical and Molecular Characterization

    Clinical Colorectal Cancer, Vol. 16, Núm. 1, pp. 31-37

2016

  1. Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

    Leukemia & lymphoma, Vol. 57, Núm. 1, pp. 86-91

  2. The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

    British journal of haematology, Vol. 172, Núm. 3, pp. 428-438

2015

  1. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations

    British Journal of Haematology

2014

  1. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

    Leukemia, Vol. 28, Núm. 4, pp. 823-829

2013

  1. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)

    Cancer, Vol. 119, Núm. 9, pp. 1660-1668

2002

  1. Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas

    European Journal of Endocrinology, Vol. 146, Núm. 2, pp. 209-213